Drug development

New research could help address heart problems in diabetics

Research published in Experimental Physiology shows that diabetes-induced changes in heartbeat are primarily regulated by the β1-adrenoceptor. This discovery, once confirmed in humans, may lead to better treatment of heart problems in diabetics by enabling more targeted drugs to be produced.

A new discovery in certain receptors of diabetes patients may give insights on...
A new discovery in certain receptors of diabetes patients may give insights on how to counteract heart problems.
Source: Universitätsklinikum Heidelberg

Patients with type 2 diabetes can have problems with the regulation of their heartbeat. The heartbeat is partly regulated by receptors called beta-adrenoceptors. There are two different forms, the β1 and β2, and each has a different function. The study found that the diabetes-induced changes in heartbeat are predominantly regulated by the β1-adrenoceptor, and not the β2-adrenoceptor.

Beta-blockers block hormones like adrenaline and can be used to decrease heart rate and blood pressure in the treatment of conditions such as angina or high blood pressure. Some beta-blockers are not effective in reducing the heartbeat of diabetics and can even worsen the blood glucose levels of patients. It is not known which beta-adrenoceptor type is responsible for these effects. This study suggests that beta-blockers targeting the β1-adrenoceptor would be more effective for diabetics.

The researchers implanted two devices into a rat model of diabetes. The first device measured blood pressure and heartbeat, and the second device injected drugs that reduce heartbeat by targeting the beta-adrenoceptors. This approach allowed the researchers to distinguish between the contributions of the two different beta-adrenoceptors (β1 and b2). Regis Lamberts, corresponding author said, 'This study provides novel insight into the pathological basis of heart rate dysregulation in type 2 diabetes. This could help us develop drugs to better address heart problems in diabetics.'

 

Source: The Physiological Society

24.05.2017

Read all latest stories

Related articles

Photo

News • Study on meth, cannabis, cocaine and opiate use

Illicit drugs linked with atrial fibrillation

Methamphetamines, cocaine, opiates, and cannabis are associated with an increased likelihood of developing atrial fibrillation, a newly-published 11-year study shows.

Photo

News • Drug delivery research

'Tunneling' capsule to enable oral insulin intake

A newly developed capsule that tunnels through mucus in the GI tract could be used to orally administer large protein drugs such as insulin.

Photo

News • Study shows elevated risk

Finding connections between diabetes and heart valve disease

Individuals with diabetes display a substantially increased risk of disease in left-sided heart valves compared to controls without diabetes, a new comprehensive register study shows.

Related products

Alphenix Biplane High Definition Detector

Bi-Plane

Canon · Alphenix Biplane High Definition Detector

Canon Medical Systems Europe B.V.
Alphenix Core

Single Plane

Canon · Alphenix Core

Canon Medical Systems Europe B.V.
Subscribe to Newsletter